NDC 58768-001-02 - Ocupress
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58768-001
- Requested NDC
- 58768-001-02
- Package NDCs from labels
- 58768-001-01, 58768-001-02, 58768-001-04
- Manufacturer
- Novartis Ophthalmics
- Effective date
- 2006-09-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ocupress - Novartis Ophthalmics | Novartis Ophthalmics | 2006-09-19 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58768-001-01 | Ocupress | 5 mL in 1 BOTTLE, DISPENSING | SOLUTION | 5 | 1 | |
| 58768-001-02 | Ocupress | 10 mL in 1 BOTTLE, DISPENSING | SOLUTION | 10 | 1 | |
| 58768-001-04 | Ocupress | 15 mL in 1 BOTTLE, DISPENSING | SOLUTION | 15 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| carteolol hydrochloride | ACTIVE INGREDIENT | 4797W6I0T4 | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | |
| carteolol | ACTIVE MOIETY | 8NF31401XG | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | |
| Benzalkonium chloride | INACTIVE INGREDIENT | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | ||
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | |
| sodium phosphate, dibasic | INACTIVE INGREDIENT | GR686LBA74 | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | |
| sodium phosphate, monobasic | INACTIVE INGREDIENT | 3980JIH2SW | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | OCUPRESS (CARTEOLOL HYDROCHLORIDE) SOLUTION [NOVARTIS OPHTHALMICS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carteolol Hydrochloride | CARTEOLOL HYDROCHLORIDE | Sandoz Inc | 571fe550-399d-4296-835c-37aa1ab9b409 | 2025-04-01 | Warnings, Adverse reactions | 978573 |
| 5F82E53E-D6DB-432F-AF68-9DE88D1B1720 | 5F82E53E-D6DB-432F-AF68-9DE88D1B1720 | 2006-09-19 | Warnings, Adverse reactions | 5F82E53E-D6DB-432F-AF68-9DE88D1B1720 5F82E53E-D6DB-432F-AF68-9DE88D1B1720 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.